A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study To Assess The Safety, Tolerability, and Efficacy Of Oral Ketamine in Patients with Rett Syndrome

Grant

Date/time Interval

  • July 16, 2019 - January 21, 2022

    • Awarded By

    Total Award Amount

  • 33950.00

    • Direct Costs

  • 33950.00

    • Sponsor Award Id

    • Contributor

  • Alan Percy   Principal Investigator